Global Health

Global Health

1,251.80
-28.90
(-2.26%)
hide
Key Fundamentals
Add Ratio
Market Cap
34,424.00 Cr
EPS
17.92
PE Ratio
62.98
Dividend Yield
0.00 %
52 Week High
1,456.50
52 Week Low
996.45
PB Ratio
9.93
Debt to Equity
0.24
Sector
Hospitals
Analyst Rating and Forecast
- By Refinitiv from11 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+63.64 %
+63.64 %
Hold
Hold+18.18 %
+18.18 %
Sell
Sell+18.18 %
+18.18 %
Forecast For
Actual

Company News

View All News
Caret
positive
Global Health Limited (Medanta) launched a new 550-bed super specialty hospital in Noida in September 2025, strengthening its presence in Delhi/NCR. The company reported consolidated total income of INR 11,189 million in Q2 FY26, up 14.8% year-on-year and 6.4% quarter-on-quarter. EBITDA excluding Noida grew 13.7% year-on-year to INR 2,804 million with margins of 25.2%. Net profit increased 21.1% year-on-year to INR 1,584 million. The Noida facility generated revenue of INR 39 million but recorded an EBITDA loss of INR 197 million during initial operations. The company added 37 new beds at Patna during the quarter and onboarded over 200 doctors across its network. International patient revenue increased 48.5% year-on-year to INR 762 million. The company also announced plans for a 750-bed hospital in Mumbai with an estimated project cost of INR 15,300 million and acquired 3.5 acres in Guwahati for INR 600 million for future expansion.
positive
Global Health plans to achieve double-digit revenue growth through expansion of high-end specialties and regional hubs. The company will add over 1,000 beds by FY28 across Lucknow, Indore, and Patna. The expansion includes investments in advanced robotics, transplant, and oncology infrastructure. The company aims to strengthen margins through case-mix optimization, operational leverage, and an asset-light expansion model.
positive
Global Health Limited announced its quarterly results with revenue from operations reaching ₹9,264.28 million and profit after tax of ₹1,401.99 million. The company's Board approved increasing the bed capacity of its proposed Mumbai hospital from 500 to 750 beds following additional FSI approval from MHADA. The expansion includes acquisition of 30 residential flats for staff accommodation, raising the total Mumbai project cost to ₹1,530 crores from the earlier estimate of ₹1,200 crores. During the period, the company's Noida and Ranchi hospitals commenced operations, and it received in-principle approval for 3.5 acres of land in Assam. The Board also approved granting 605,500 stock options to eligible employees and allotted 183,000 shares under the employee welfare trust.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
7,642.00
#1 1,11,893.20
63.52
#1 21,994.30
14.76
#1 1,505
24.84
42.00
1,135.30
1,09,415.50
96.26
7,184.10
#1 28.65
1,076
30.34
42.09
1,020.00
76,243.20
85.38
7,849.70
13.25
809
#1 53.33
46.87
1,810.40
37,191.60
#1 47.09
5,575.00
12.29
790
-2.38
56.11
692.90
35,607.90
98.49
4,286.70
15.12
337
14.65
55.01
1,251.80
#6 34,424.00
#4 62.98
#6 3,771.40
#9 12.59
#5 481
#5 21.10
35.74
728.10
28,822.00
81.87
3,067.00
21.98
415
-40.35
52.74
1,373.50
13,849.60
54.04
1,566.90
17.46
244
35.52
49.85
759.60
10,649.70
258.94
2,257.70
17.03
49
-55.88
61.31
1,551.90
10,186.30
52.86
1,290.20
17.77
194
11.65
54.22
Growth Rate
Revenue Growth
12.59 %
Net Income Growth
0.67 %
Cash Flow Change
1.91 %
ROE
-13.62 %
ROCE
-9.67 %
EBITDA Margin (Avg.)
-2.80 %

Quarterly Financial Results

Quarterly Financials
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Revenue
492
588
593
533
627
695
706
732
795
865
855
836
883
975
960
954
1,051
1,119
Expenses
386
442
448
441
485
523
534
540
595
631
621
629
675
728
706
757
784
852
EBITDA
106
146
146
92
142
172
172
192
199
234
234
207
208
247
254
198
267
267
Operating Profit %
21 %
24 %
23 %
15 %
21 %
23 %
23 %
24 %
24 %
25 %
26 %
22 %
22 %
24 %
25 %
19 %
24 %
22 %
Depreciation
31
31
33
35
36
37
39
38
40
43
44
46
47
49
49
49
45
50
Interest
16
17
18
28
19
18
21
21
18
20
18
18
18
16
16
15
14
17
Profit Before Tax
58
98
95
29
87
117
112
133
141
171
172
143
144
181
189
133
208
200
Tax
16
31
25
12
28
31
32
32
39
45
49
16
37
50
46
32
49
41
Net Profit
42
67
70
18
59
86
81
101
102
125
124
127
106
131
143
101
159
158
EPS in ₹
5.13
13.22
2.76
0.69
2.32
3.38
3.08
3.77
3.80
4.66
4.61
4.74
3.96
4.87
5.32
3.77
5.92
5.89

Balance Sheet

Balance Sheet
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
1,984
2,430
0
2,694
3,146
4,116
4,304
4,766
Fixed Assets
1,094
1,194
0
1,616
1,776
2,050
2,236
2,514
Current Assets
472
489
0
502
812
1,580
1,509
1,533
Capital Work in Progress
317
666
0
464
439
327
388
533
Investments
0
0
0
0
0
0
0
3
Other Assets
573
570
0
615
930
1,739
1,681
1,716
Total Liabilities
1,984
2,430
0
2,694
3,146
4,116
4,304
4,766
Current Liabilities
334
296
0
405
420
573
618
619
Non Current Liabilities
432
839
0
907
1,110
1,115
781
760
Total Equity
1,217
1,296
0
1,382
1,616
2,428
2,906
3,388
Reserve & Surplus
1,136
1,214
0
1,300
1,565
2,375
2,852
3,333
Share Capital
81
49
0
50
51
54
54
54

Cash Flow

Cash Flow
2015
2016
2018
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
-0
-20
3
14
87
-78
50
648
-343
-194
Investing Activities
-126
-241
-69
-249
-87
-239
-421
-342
-441
-721
Operating Activities
213
228
63
166
175
242
311
645
612
624
Financing Activities
-88
-7
9
97
-1
-81
160
346
-514
-97

Share Holding

% Holding
Sept 2021
Oct 2022
Nov 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Promoter
35.04 %
35.03 %
33.08 %
33.08 %
33.08 %
33.07 %
33.06 %
33.05 %
33.04 %
33.04 %
33.04 %
33.03 %
33.03 %
33.01 %
33.01 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
10.69 %
0.00 %
12.09 %
12.94 %
12.20 %
12.47 %
11.76 %
11.54 %
11.40 %
DIIs
0.00 %
0.00 %
7.78 %
12.55 %
12.35 %
10.80 %
10.93 %
9.68 %
10.25 %
10.57 %
11.11 %
10.51 %
11.93 %
12.20 %
12.98 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
0.00 %
25.44 %
6.16 %
5.77 %
6.79 %
6.85 %
6.79 %
7.14 %
6.28 %
6.54 %
6.74 %
6.53 %
6.48 %
6.03 %
Others
64.96 %
64.97 %
33.69 %
48.21 %
48.80 %
49.34 %
38.48 %
50.48 %
37.47 %
37.16 %
37.10 %
37.24 %
36.75 %
36.77 %
36.58 %
No of Share Holders
47
48
2,86,944
1,21,407
1,07,120
1,09,798
1,16,627
1,24,775
1,66,253
1,55,307
1,49,722
1,48,633
1,54,688
1,56,372
1,55,806

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
03 Aug 2024 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
03 Aug 2024 1,306.70 1,209.25
19 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
19 Sept 2024 1,191.50 1,113.90
14 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Nov 2024 1,073.35 1,032.55
04 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
04 Feb 2025 1,001.20 1,042.50
15 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
15 May 2025 1,203.60 1,241.80
07 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
07 Aug 2025 1,355.40 1,339.10
22 Aug 2025 DIVIDEND Dividend
₹ 0.50 /share
22 Aug 2025 1,241.80 1,389.30
19 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
19 Sept 2025 1,339.10 1,367.70
07 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
07 Nov 2025 1,348.70 1,280.70

Announcements

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation13 hours ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation14 hours ago
Announcement under Regulation 30 (LODR)-Investor Presentation15 hours ago
Announcement under Regulation 30 (LODR)-Press Release / Media Release15 hours ago
Announcement Under Regulation 30 Of Listing Regulations.16 hours ago
Results For The Quarter & Half Year Ended September 30 202516 hours ago
Board Meeting Outcome for Board Meeting Outcome For Intimation Under Regulation 30 Of SEBI Listing Regulation16 hours ago
Announcement under Regulation 30 (LODR)-Change in Management1 day ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation6 days ago
Announcement under Regulation 30 (LODR)-Press Release / Media Release7 days ago
Board Meeting Intimation for Schedule Of Board Meeting For Second Quarter And Half Year Ended September 30 2025 Under Regulation 29 Of Listing Regulations10 days ago
Announcement Under Regulation 30 Of Listing Regulations.Oct 25, 2025
Announcement under Regulation 30 (LODR)-Credit RatingOct 17, 2025
Disclosure under Regulation 30A of LODROct 17, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 07, 2025
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations) - ESG Rating Assigned By CRISILOct 07, 2025
Disclosures under Reg. 29(1) & 29(2) of SEBI (SAST) Regulations 2011Oct 04, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 25, 2025
Closure of Trading WindowSep 25, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 24, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 24, 2025
Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 19, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 19, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 17, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 17, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 10, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 09, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 09, 2025
Announcement Under Regulation 30 Of Listing RegulationsSep 04, 2025
Announcement Under Regulation 30 Of Listing RegulationsSep 01, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 29, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 29, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 29, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 29, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 29, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 26, 2025
Letter To Shareholders Providing The Weblink Of Annual Report For The FY 2024-25Aug 26, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 25, 2025
Business Responsibility and Sustainability Reporting (BRSR)Aug 25, 2025
Notice Of 21St Annual General Meeting Scheduled To Be Held On Friday September 19 2025 Through Video Conferencing (VC)/ OAVM For The Financial Year 2024-25.Aug 25, 2025
Reg. 34 (1) Annual Report.Aug 25, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 19, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptAug 15, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 12, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 11, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 11, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 11, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 11, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeAug 08, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 08, 2025

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Kotak Midcap Fund Direct-Growth
0.00%
-7518801
-1.69%
-1.81%
Canara Robeco Large and Mid Cap Fund Direct-Growth
0.00%
-2312524
-1.19%
-1.25%
Invesco India Mid Cap Fund Direct-Growth
0.00%
-2201928
-3.40%
-3.05%
Invesco India Contra Fund Direct-Growth
0.00%
-1937567
-1.33%
-1.40%
Invesco India Smallcap Fund Direct - Growth
0.00%
-1578766
-2.58%
-2.81%
Invesco India Large & Mid Cap Fund Direct-Growth
0.00%
-1547479
-2.41%
-2.62%
Invesco India Focused Fund Direct - Growth
0.00%
-1368138
-4.28%
-4.54%
PGIM India Midcap Fund Direct-Growth
0.00%
-1271978
-1.48%
-1.53%
Canara Robeco Small Cap Fund Direct - Growth
0.00%
-1104062
-1.13%
-1.21%
HSBC Midcap Fund Direct-Growth
0.00%
-951822
-1.05%
-1.11%
PGIM India Flexi Cap Fund Direct-Growth
0.00%
-568966
-1.21%
-1.55%
Canara Robeco Mid Cap Fund Direct - Growth
0.00%
-560071
-2.08%
-2.20%
Invesco India Flexi Cap Fund Direct - Growth
0.00%
-465439
-1.53%
-1.53%
Kotak Contra Fund Direct-Growth
0.00%
-458879
-1.28%
-1.40%
Invesco India Multicap Fund Direct-Growth
0.00%
-412576
-1.33%
-1.40%
HSBC Consumption Fund Direct - Growth
0.00%
-384300
-2.97%
-3.21%
HSBC Flexi Cap Fund Direct-Growth
0.00%
-338207
-0.88%
-0.93%
Canara Robeco Multi Cap Fund Direct - Growth
0.00%
-286528
-0.81%
-0.86%
Invesco India Business Cycle Fund Direct-Growth
0.00%
-220441
-3.82%
-3.50%
HSBC Aggressive Hybrid Fund Direct-Growth
0.00%
-214000
-0.51%
-0.54%
360 ONE Flexicap Fund Direct - Growth
0.00%
-201381
-1.32%
-1.40%
Nippon India Multi Asset Allocation Fund Direct - Growth
0.00%
-200000
-0.34%
-0.39%
UTI Mid Cap Fund Direct-Growth
0.76%
200000
0.20%
0.59%
PGIM India Small Cap Fund Direct - Growth
0.00%
-175412
-1.47%
-1.94%
HSBC Multi Asset Allocation Fund Direct - Growth
0.00%
-127033
-0.73%
-0.80%

Technical Indicators

RSI(14)
Neutral
35.74
ATR(14)
Volatile
38.01
STOCH(9,6)
Neutral
21.27
STOCH RSI(14)
Oversold
13.45
MACD(12,26)
Bearish
-12.83
ADX(14)
Weak Trend
19.80
UO(9)
Bearish
39.02
ROC(12)
Downtrend And Accelerating
-9.58
WillR(14)
Oversold
-86.62

About Global Health

Global Health Limited is a private multi-specialty tertiary care provider operating in North and East India. Founded by Dr. Naresh Trehan, the company operates under the Medanta brand with a network of 5 operational hospitals and one under construction. As of June 30, 2022, they offered healthcare services in over 30 medical specialties, employed over 1,300 doctors, and had 2,467 installed beds across 4.7 million sq. ft. of area. The company operates hospitals in Gurugram, Indore, Ranchi, Lucknow, and Patna, with specialties including cardiology, neurosciences, oncology, and orthopedics. Global Health Limited went public in November 2022, raising Rs. 2205.57 crores through an IPO. The company has been expanding its facilities, adding beds, doctors, and new medical equipment across its hospitals.
Listing Date
16 Nov, 2022(2 Years, 23 days)
Chairperson NameNaresh Kumar Trehan